BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu G, Tang F, Wang T, Yan JQ, Li FH, Ha FS, Zhang X, Jing L, Liang J. Efficacy of recombinant human thrombopoietin in patients with acute-on-chronic liver failure and thrombocytopenia: A prospective, open-label study. World J Gastroenterol 2025; 31(14): 105004 [PMID: 40248371 DOI: 10.3748/wjg.v31.i14.105004]
URL: https://www.wjgnet.com/1948-9366/full/v31/i14/105004.htm
Number Citing Articles
1
Xun Wei, Li Ma, Wen Bo Liu, Ya Mei Kuang, Xin Meng Qin, Jun Feng Wei, Yi Kang. Recombinant human thrombopoietin for chronic liver disease-associated thrombocytopenia with or without concomitant infections: a real-world retrospective studyFrontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1732969
2
Kefeng Jin, Peng Wang, Xiuqin Yang, Xiaofei Zhang, Tao Huang, Yue Qiu, Mo Li, Yuan Wang, Xue Ma. Toxicokinetics under extracorporeal clearance and temporal dissociation of hepatotoxicity and coagulopathy in ACDMB poisoning: Two index casesToxicology Reports 2026; 16 doi: 10.1016/j.toxrep.2026.102277